ENDRA Life Sciences NDRA
NASDAQ NDRA
$4.80 +0.02 (+0.42%)
As of: Oct 23, 2026 · 3:57 PM EDT

ENDRA Life Sciences (NDRA) Asset Writedowns and Impairment (2018 - 2019)

Updated

ENDRA Life Sciences (NDRA) recorded Asset Writedowns and Impairment of $249,256 in Q4 2019.

Analysis

ENDRA Life Sciences (NDRA) Asset Writedowns and Impairment (2018 - 2019) Analysis & Trends

  • Across earlier years, Asset Writedowns and Impairment came in at $287,541 in FY2018.
  • The Q4 2019 figure is the highest quarterly Asset Writedowns and Impairment since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 ENDRA Life Sciences 6.36 Mn 2.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 249,256.00
Sep 30, 2018 287,541.00
API Access

ENDRA Life Sciences Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=NDRA&period=max&api_key=YOUR_API_KEY